Hackensack, New Jersey Clinical Trials

A listing of Hackensack, New Jersey clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 193 clinical trials
Community-based Implementation of Online EmReg

This is a hybrid type III implementation-effectiveness trial; this study design blends elements of implementation and clinical effectiveness research, with the primary aim of determining the utility of an implementation strategy and a secondary aim of assessing clinical outcomes associated with the implementation trial. Consistent with best practices for this …

Accepts healthy volunteers
Icahn School of Medicine at Mount Sinai
 (8.6 away) Contact site
  • 0 views
  • 11 Jul, 2023
  • 1 location
Asthma 2  

Asthma 2

P Site 2
 (7.4 away)
  • 0 views
  • 16 Feb, 2024
  • 1 location
2019-06 TRISCEND Study

Early feasibility study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System

medical therapy
tricuspid valve replacement
Columbia University Irving Medical Center / NYPH
 (6.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

An open-label, multi-center, single and cyclic ascending dose study of P-PSMA-101 autologous CAR-T cells in patients with mCRPC.

metastatic hormone refractory prostate cancer
metastatic castration-resistant prostate cancer
rimiducid
metastatic cancer
metastasis
Memorial Sloan Kettering Cancer Center
 (9.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +2 other locations
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

Lorenc Aesthetic Plastic Surgery Center
 (9.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

This is an open-label, dose escalation study to evaluate the safety, toxicity, and pharmacokinetics (PK) as well as preliminary efficacy of BTX-A51 capsules in participants with relapsed or refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS). The study will be done in two phases. Phase 1a of this …

leukemia
exhaustion
exhausted
acute myeloid leukemia
cancer therapy
Memorial Sloan-Kettering Cancer Center
 (9.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
TKR With and Without the Use of Intra-operative Sensing

The purpose of this study is to determine if there is a difference in clinical outcomes after total knee replacement (TKR) performed with traditional ligament balancing compared to use of intraoperative sensing technology (IOS) to balance ligaments. IOS is used to send real time information to a monitor within the …

osteoarthritis
total knee replacement
Hospital for Special Surgery
 (9.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated Nonsquamous NSCLC

This is a Phase 2, randomized, multicenter, double-blind study of the glutaminase inhibitor telaglenastat with standard-of-care pembrolizumab and chemotherapy versus placebo with standard-of-care pembrolizumab and chemotherapy for first line treatment of metastatic disease in patients with KEAP1/NRF2-mutated, stage IV, nonsquamous, non-small cell lung cancer (NSCLC). The study primary endpoints are …

metastasis
measurable disease
EGFR
stage iv non-small cell lung cancer
pemetrexed
New Jersey Cancer Care and Blood Disorders (NJCCBD)
 (8.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +27 other locations
CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas

The blood brain barrier (BBB) prevents some drugs from successfully reaching the target source. Convection-Enhanced Delivery (CED) is a method of direct infusion of drugs under controlled pressure to the tumor that may reduce systemic side effects of drugs in the patient. The purpose of this Phase I study is …

platelet count
side effects of drugs
glioma
acute infection
epilepsy
Columbia University Irving Medical Center
 (6.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment

A Phase1/2a Study of Rigosertib plus Nivolumab in Stage IV Lung Adenocarcinoma Patients with KRAS Mutation who Progressed on First-Line Treatment

metastatic lung adenocarcinoma
lung cancer
measurable disease
drug test
stage iv lung adenocarcinoma
Icahn School of Medicine at Mount Sinai
 (8.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location